Zehra Hooda, DO
Pain Medicine · Bellaire, TXNPI 1487097523
Payments from drug & device makers
Across 212 payments — averaging $26.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$826
- Nevro Corp.$809
- Globus Medical$569
- Collegium Pharmaceutical, Inc.$438
- Medtronic$393
- Amgen$339
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,709100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 28 | $826 |
| Nevro Corp. | 15 | $809 |
| Globus Medical | 15 | $569 |
| Collegium Pharmaceutical, Inc. | 20 | $438 |
| Medtronic | 9 | $393 |
| Amgen | 20 | $339 |
| AbbVie | 14 | $300 |
| Ferring Pharmaceuticals Inc. | 17 | $289 |
| Scilex Pharmaceuticals Inc. | 9 | $216 |
| Azurity Pharmaceuticals, Inc. | 7 | $167 |
| Bioventus LLC | 7 | $153 |
| Sanofi-aventis U.S. LLC | 7 | $133 |
| Abbott | 2 | $129 |
| Pacira Pharmaceuticals Incorporated | 4 | $109 |
| Boston Scientific | 5 | $107 |
| Averitas Pharma Inc. | 4 | $103 |
| Nalu Medical, Inc. | 1 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| Fidia Pharma USA Inc. | 4 | $49 |
| Zimmer Biomet | 2 | $49 |
| Pfizer | 2 | $48 |
| Kaleo, Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Painteq LLC | 1 | $30 |
| Johnson & Johnson | 2 | $28 |
| Biotronik NRO, Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| Curonix LLC | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Medinc Of Texas | 1 | $15 |
| Impel Pharmaceuticals LLC | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$527
- SYNCHROMEDII$140
- Zilretta$119
- Proclaim Family of SCS IPGs$108
How this compares
$5,717 in reported general payments places this provider in the 60th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $742 |
| Gabapentin | 45 | $549 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 27 | $311 |
| Tramadol Hcl | 21 | $222 |
| Tizanidine Hcl | 40 | $179 |
| Cyclobenzaprine Hcl | 22 | $121 |
| Meloxicam | 40 | $61 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Bellaire
- Thomas BurgessBellaire$26K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.